Application Notes & Case Studies

  1. Streamlining Phase 1 Trials With The Mobile Vision Pod 1/29/2025

    A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.

  2. Expanding Diabetes-Related Eye Health Equity 1/29/2025

    20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.

  3. Expanding Access To Post-Market Safety Exams For Cystic Fibrosis Medication 1/29/2025

    This study highlights the transformative impact of point-of-need care on patient access, focusing on pediatric cystic fibrosis (CF) patients requiring essential eye exams.

  4. Overcoming Unexpected Obstacles In A Phase 1 Study 1/29/2025

    Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.

  5. Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments 1/29/2025

    During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.

  6. Use Case: A Patient-Centric Approach To Site Selection 1/27/2025

    Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease. 

  7. Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments 1/15/2025

    Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

  8. Optimizing Early-Stage Oncology 1/14/2025

    A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.

  9. Addressing Site Selection Challenges In DMD Gene Therapy Studies 1/14/2025

    Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.

  10. Breaking Free From Process Paralysis In Clinical Trials 1/13/2025

    Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.